Cinacalcet

BreastfeedingPediatric
  • TRADE NAMES: Mimpara (Amgen); Sensipar (Amgen)
  • INDICATIONS: Secondary hyperparathyroidism, parathyroid carcinoma
  • CLASS: Calcimimetic
  • HALF-LIFE: 30–40 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Amitriptyline, Antifungal agents, Atomoxetine, Carvedilol, Codeine, Conivaptan, CYP2D6 substrates, CYP3A4 inhibitors, Dasatinib, Desipramine, Fesoterodine, Flecainide, Food, Itraconazole, Ketoconazole, Metoprolol, Nebivolol, PEG-Interferon, Tacrolimus, Tamoxifen, Tetrabenazine, Thioridazine, Tramadol, Tricyclic antidepressants, Voriconazole

PREGNANCY CATEGORY: C

Contra-indicated in patients with hypocalcemia.

Our database has 38 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 03/25/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top